封面
市場調查報告書
商品編碼
1413722

全球認知健康成分市場預測(截至2030年)

Cognitive Health Ingredients Market Research Report Forecast till 2030

出版日期: | 出版商: Market Research Future | 英文 186 Pages | 訂單完成後即時交付

價格

市場概況

研究期間,全球認知健康成分市場規模預計將以 8.43% 的複合年增長率穩定成長。隨著人們對認知健康和與年齡相關的認知功能下降的興趣和擔憂增加,人們對含有認知健康成分的產品的興趣也在擴大。此外,許多已開發國家的人口老化也推動了這一趨勢,推動認知健康產品的購買者基礎不斷擴大。

提高認知健康意識是市場成長的重要推手。近年來,人們的心理健康意識發生了顯著變化。隨著人口老化以及阿茲海默症和失智症等認知問題的日益普遍,保持認知能力的重要性已上升到人們意識的前沿。

區域分析

2022年北美市場佔比將達到34.86%,評級機構預計複合年增長率為8.03%。其強大的醫療框架和對認知健康重要性的日益認識使美國在北美市場佔據了強勢地位。近年來,人們對老化和認知能力下降的擔憂導致人們對 omega-3 不飽和脂肪酸等認知健康成分越來越感興趣。

在亞太市場,隨著人口老化和生活方式的發展,買家變得更加註重健康,對提高認知能力的產品越來越感興趣。

本報告研究和分析了全球認知健康成分市場,提供市場動態、區域和細分分析、公司簡介等。

目錄

第一章執行摘要

    • 全球認知健康成分市場:按類型
    • 全球認知健康成分市場:依最終用途分類
    • 全球認知健康成分市場:按分銷管道
    • 全球認知健康成分市場:按地區

第二章市場介紹

第三章研究方法

第四章市場動態

  • 介紹
  • 促進者
    • 提高認知健康意識
    • 世界各地老年人口不斷增加
    • 促進因素影響分析
  • 抑制因素
    • 認知健康成分的嚴格監管要求和批准
    • 對某些成分的潛在副作用和安全問題的擔憂阻礙了採用
    • 抑制因素影響分析
  • 機會
    • 對個人化營養的需求不斷增長
  • COVID-19 對全球經濟的影響
  • COVID-19 對全球認知健康成分市場的影響
  • 對供應鏈的影響
    • 對製造商的影響
    • 對原物料供應商的影響
    • 對配送/物流的影響

第五章市場因素分析

  • 供應鏈/價值鏈分析
    • 原物料供應商
    • 製造/包裝
    • 分銷/銷售渠道
    • 零售商、最終用戶
  • 波特五力分析模型

第六章全球認知健康成分市場:依類型

  • 概述
  • 全球認知健康成分市場規模、市場估計與預測:按類型(2019-2030)

第七章全球認知健康成分市場:依最終用途分類

  • 概述
  • 全球認知健康成分市場規模、市場估計與預測:按最終用途分類(2019-2030)

第八章全球認知健康成分市場:按分銷管道

  • 概述
  • 全球認知健康成分市場規模、市場估計與預測:按分銷管道劃分(2019-2030)

第九章全球認知健康成分市場:按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞/新西蘭
    • 亞太其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 中東/非洲
    • 海灣合作委員會國家
    • 土耳其
    • 北非
    • 南非

第10章競爭格局

  • 競爭概況
  • 競爭標桿
  • 全球認知健康成分市場的主要參與者
  • 全球認知健康成分市場多項開發成果的領導者
  • 主要發展和增長戰略
    • 產品上市/產品開發/核准
    • 擴張和收購/合作夥伴關係

第十一章公司簡介

  • KEMIN INDUSTRIES, INC.
  • NEXIRA
  • ARLA FOOD INGREDIENTS GROUP
  • AUREA BIOLABS
  • BIORIGINAL FOOD & SCIENCE CORP
  • BIOTROPICS MALAYSIA BERHAD
  • NATURAL FACTORS NUTRITIONAL PRODUCTS LTD
  • NOW FOODS
  • INTELLIGENT LABS
  • BASF SE

第十二章附錄

Product Code: MRFR/F-B & N/5095-CR

Market Overview

Global Cognitive Health Ingredients Market is projected to register a healthy CAGR of 8.43% during the review period. The worldwide cognitive health ingredients market has encountered dynamic changes as of late determined by a few key variables. The developing mindfulness and concern in regard to cognitive health and age-related cognitive decay have filled expanded interest for items containing cognitive health ingredients. This pattern has been additionally advanced by the maturing populace in many created nations, prompting a bigger purchaser base looking for cognitive health arrangements.

Expanding consciousness of cognitive health is a vital driver behind the development of the worldwide cognitive health ingredients market. Throughout recent years, there has been a huge change in individuals' discernments in regard to mind health. With a maturing populace and expanding examples of cognitive issues like Alzheimer's illness and dementia, the significance of keeping up with cognitive capability has come to the very front of public awareness.

This elevated mindfulness is a consequence of expanded schooling and data largely spread about cognitive health. The web, online entertainment, and customary media channels play had a vital impact in spreading information about the meaning of cerebrum health. People are presently more proactive in looking for ways of improving and save their cognitive capacities, and this has converted into a flood popular for cognitive health items and ingredients.

Market Segmentation

The global cognitive health ingredients market segmentation is based on the type, such as omega-3 fatty acids, B-vitamins, vitamin E, citicoline, caffeine, adaptogens, and others.

Based on end-use the market is classified into human nutrition products, and animal nutrition products. The distribution channels segment includes direct and indirect.

Regional Analysis

The North America cognitive health ingredients market represented 34.86% in 2022 and is expected to develop with a CAGR of 8.03% during the assessed years. The US stands firm on a conspicuous footing in the North American cognitive health ingredients market because of its vigorous healthcare framework and developing familiarity with the significance of cognitive health. As of late, there has been a rising interest for cognitive health ingredients, like omega-3 unsaturated fats, cell reinforcements, and nutrients, driven by the maturing populace and worries about cognitive decay.

Europe is ready to rise to the place of the third-biggest worldwide market for food supplements, following Asia-Pacific and North America. According to information from Food Enhancements Europe, a critical 52% of European customers settle on dietary enhancements to maintain their general prosperity.

The Asia Pacific cognitive health ingredients market is encountering significant development driven by an expanded spotlight on mental prosperity. With a blossoming maturing populace and evolving ways of life, buyers in the region are turning out to be more health-cognizant, filling the interest in items that upgrade cognitive capabilities. Customary ingredients like ginseng and turmeric have acquired ubiquity for their cognitive advantages.

Market Overview

Key Companies in the Cognitive Health Ingredients market include Kemin Industries, Inc. (US), Nexira (France), Arla Food Ingredients Group (Denmark), Aurea Biolabs (India), Bioriginal Food & Science Corp (Canada), Biotropics Malaysia Berhad (Malaysia), Natural Factors Nutritional Products Ltd (Canada), NOW Foods (US), Intelligent Labs (UK), and BASF SE (Germany).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 14

    • 1.1.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE 16
    • 1.1.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE 17
    • 1.1.3 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL 18
    • 1.1.4 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION 19

2 MARKET INTRODUCTION 20

  • 2.1 DEFINITION 20
  • 2.2 SCOPE OF THE STUDY 20
  • 2.3 MARKET STRUCTURE 21
  • 2.4 KEY BUYING CRITERIA 21

3 RESEARCH METHODOLOGY 22

  • 3.1 RESEARCH PROCESS 22
  • 3.2 PRIMARY RESEARCH 23
  • 3.3 SECONDARY RESEARCH 24
  • 3.4 MARKET SIZE ESTIMATION 24
  • 3.5 TOP DOWN & BOTTOM-UP APPROACH 25
  • 3.6 FORECAST MODEL 26
  • 3.7 LIST OF ASSUMPTIONS 27

4 MARKET DYNAMICS 28

  • 4.1 INTRODUCTION 28
  • 4.2 DRIVERS 29
    • 4.2.1 INCREASING AWARENESS OF COGNITIVE HEALTH 29
    • 4.2.2 GROWING AGING POPULATION WORLDWIDE 29
    • 4.2.3 DRIVERS IMPACT ANALYSIS 30
  • 4.3 RESTRAINTS 30
    • 4.3.1 STRINGENT REGULATORY REQUIREMENTS AND APPROVALS IN THE COGNITIVE HEALTH INGREDIENTS 30
    • 4.3.2 CONCERNS REGARDING POTENTIAL SIDE EFFECTS OR SAFETY ISSUES OF CERTAIN INGREDIENTS LIMIT ADOPTION 31
    • 4.3.3 RESTRAINTS IMPACT ANALYSIS 31
  • 4.4 OPPORTUNITIES 32
    • 4.4.1 GROWING DEMAND FOR PERSONALIZED NUTRITION 32
  • 4.5 IMPACT OF COVID-19 ON GLOBAL ECONOMY 32
  • 4.6 IMPACT OF COVID-19 ON THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 33
  • 4.7 SUPPLY CHAIN IMPACT 34
    • 4.7.1 IMPACT ON MANUFACTURER 34
    • 4.7.2 IMPACT ON RAW MATERIAL SUPPLIER 34
    • 4.7.3 IMPACT ON DISTRIBUTION/LOGISTICS 34

5 MARKET FACTOR ANALYSIS 35

  • 5.1 SUPPLY/VALUE CHAIN ANALYSIS 35
    • 5.1.1 RAW MATERIALS SUPPLIERS 35
    • 5.1.2 MANUFACTURING & PACKAGING 35
    • 5.1.3 DISTRIBUTION & SALES CHANNEL 36
    • 5.1.4 RETAILERS AND END-USERS 36
  • 5.2 PORTER'S FIVE FORCES MODEL 36
    • 5.2.1 THREAT OF NEW ENTRANTS 37
    • 5.2.2 BARGAINING POWER OF SUPPLIERS 37
    • 5.2.3 BARGAINING POWER OF BUYERS 37
    • 5.2.4 THREAT OF SUBSTITUTES 37
    • 5.2.5 INTENSITY OF RIVALRY 37

6 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE 38

  • 6.1 OVERVIEW 38
  • 6.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40
    • 6.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY TYPE, 2019-2030 40

7 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE 41

  • 7.1 OVERVIEW 41
  • 7.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030 42
    • 7.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY END-USE, 2019-2030 42

8 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL 43

  • 8.1 OVERVIEW 43
  • 8.2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44
    • 8.2.1 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE: MARKET ESTIMATES & FORECAST BY DISTRIBUTION CHANNEL, 2019-2030 44

9 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION 45

  • 9.1 OVERVIEW 45
  • 9.2 NORTH AMERICA 47
    • 9.2.1 U.S. 49
    • 9.2.2 CANADA 50
    • 9.2.3 MEXICO 51
  • 9.3 EUROPE 53
    • 9.3.1 GERMANY 56
    • 9.3.2 FRANCE 57
    • 9.3.3 UK 58
    • 9.3.4 ITALY 59
    • 9.3.5 SPAIN 60
    • 9.3.6 REST OF EUROPE 61
  • 9.4 ASIA PACIFIC 62
    • 9.4.1 CHINA 65
    • 9.4.2 INDIA 66
    • 9.4.3 JAPAN 67
    • 9.4.4 AUSTRALIA & NEW ZEALAND 68
    • 9.4.5 REST OF ASIA PACIFIC 69
  • 9.5 SOUTH AMERICA 70
    • 9.5.1 BRAZIL 72
    • 9.5.2 ARGENTINA 73
    • 9.5.3 REST OF SOUTH AMERICA 74
  • 9.6 MIDDLE EAST & AFRICA 76
    • 9.6.1 GCC COUNTRIES 78
    • 9.6.2 TURKEY 79
    • 9.6.3 NORTHERN AFRICA 80
    • 9.6.4 SOUTHERN AFRICA 81

10 COMPETITIVE LANDSCAPE 83

  • 10.1 COMPETITIVE OVERVIEW 83
  • 10.2 COMPETITIVE BENCHMARKING 83
  • 10.3 MAJOR PLAYERS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • 10.4 LEADING PLAYERS IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 85
    • 10.5.1 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL 85
    • 10.5.2 EXPANSION/ACQUISITION/ PARTNERSHIP 85

11 COMPANY PROFILES 86

  • 11.1 KEMIN INDUSTRIES, INC. 86
    • 11.1.1 COMPANY OVERVIEW 86
    • 11.1.2 FINANCIAL OVERVIEW 86
    • 11.1.3 PRODUCTS OFFERED 86
    • 11.1.4 KEY DEVELOPMENTS 86
    • 11.1.5 SWOT ANALYSIS 87
    • 11.1.6 KEY STRATEGIES 87
  • 11.2 NEXIRA 88
    • 11.2.1 COMPANY OVERVIEW 88
    • 11.2.2 FINANCIAL OVERVIEW 88
    • 11.2.3 PRODUCTS OFFERED 88
    • 11.2.4 KEY DEVELOPMENTS 88
    • 11.2.5 SWOT ANALYSIS 89
    • 11.2.6 KEY STRATEGIES 89
  • 11.3 ARLA FOOD INGREDIENTS GROUP 90
    • 11.3.1 COMPANY OVERVIEW 90
    • 11.3.2 FINANCIAL OVERVIEW 90
    • 11.3.3 PRODUCTS OFFERED 91
    • 11.3.4 KEY DEVELOPMENTS 91
    • 11.3.5 SWOT ANALYSIS 91
    • 11.3.6 KEY STRATEGIES 91
  • 11.4 AUREA BIOLABS 92
    • 11.4.1 COMPANY OVERVIEW 92
    • 11.4.2 FINANCIAL OVERVIEW 92
    • 11.4.3 PRODUCTS/SERVICES OFFERED 92
    • 11.4.4 KEY DEVELOPMENTS 92
    • 11.4.5 SWOT ANALYSIS 93
    • 11.4.6 KEY STRATEGIES 93
  • 11.5 BIORIGINAL FOOD & SCIENCE CORP 94
    • 11.5.1 COMPANY OVERVIEW 94
    • 11.5.2 FINANCIAL OVERVIEW 94
    • 11.5.3 PRODUCTS/SERVICES OFFERED 94
    • 11.5.4 KEY DEVELOPMENTS 94
    • 11.5.5 SWOT ANALYSIS 95
    • 11.5.6 KEY STRATEGIES 95
  • 11.6 BIOTROPICS MALAYSIA BERHAD 96
    • 11.6.1 COMPANY OVERVIEW 96
    • 11.6.2 FINANCIAL OVERVIEW 96
    • 11.6.3 PRODUCTS/SERVICES OFFERED 96
    • 11.6.4 KEY DEVELOPMENTS 96
    • 11.6.5 SWOT ANALYSIS 97
    • 11.6.6 KEY STRATEGIES 97
  • 11.7 NATURAL FACTORS NUTRITIONAL PRODUCTS LTD 98
    • 11.7.1 COMPANY OVERVIEW 98
    • 11.7.2 FINANCIAL OVERVIEW 98
    • 11.7.3 PRODUCTS/SERVICES OFFERED 98
    • 11.7.4 KEY DEVELOPMENTS 98
    • 11.7.5 SWOT ANALYSIS 99
    • 11.7.6 KEY STRATEGIES 99
  • 11.8 NOW FOODS 100
    • 11.8.1 COMPANY OVERVIEW 100
    • 11.8.2 FINANCIAL OVERVIEW 100
    • 11.8.3 PRODUCTS/SERVICES OFFERED 100
    • 11.8.4 KEY DEVELOPMENTS 100
    • 11.8.5 SWOT ANALYSIS 101
    • 11.8.6 KEY STRATEGIES 101
  • 11.9 INTELLIGENT LABS 102
    • 11.9.1 COMPANY OVERVIEW 102
    • 11.9.2 FINANCIAL OVERVIEW 102
    • 11.9.3 PRODUCTS OFFERED 102
    • 11.9.4 KEY DEVELOPMENTS 102
    • 11.9.5 SWOT ANALYSIS 103
    • 11.9.6 KEY STRATEGIES 103
  • 11.10 BASF SE 104
    • 11.10.1 COMPANY OVERVIEW 104
    • 11.10.2 FINANCIAL OVERVIEW 104
    • 11.10.3 PRODUCTS OFFERED 105
    • 11.10.4 KEY DEVELOPMENTS 105
    • 11.10.5 SWOT ANALYSIS 105
    • 11.10.6 KEY STRATEGIES 106

12 APPENDIX 107

  • 12.1 REFERENCES 107

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS 27
  • TABLE 2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 40
  • TABLE 3 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 42
  • TABLE 4 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 44
  • TABLE 5 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY REGION, 2019-2030 (USD MILLION) 46
  • TABLE 6 NORTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 48
  • TABLE 7 NORTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 48
  • TABLE 8 NORTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 49
  • TABLE 9 NORTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 49
  • TABLE 10 US COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 49
  • TABLE 11 US COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 50
  • TABLE 12 US COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 50
  • TABLE 13 CANADA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 50
  • TABLE 14 CANADA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 51
  • TABLE 15 CANADA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 51
  • TABLE 16 MEXICO COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 51
  • TABLE 17 MEXICO COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 52
  • TABLE 18 MEXICO COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 52
  • TABLE 19 EUROPE: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 54
  • TABLE 20 EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 55
  • TABLE 21 EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 55
  • TABLE 22 EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 55
  • TABLE 23 GERMANY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 56
  • TABLE 24 GERMANY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 56
  • TABLE 25 GERMANY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 56
  • TABLE 26 FRANCE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 57
  • TABLE 27 FRANCE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 57
  • TABLE 28 FRANCE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 57
  • TABLE 29 UK COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 58
  • TABLE 30 UK COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 58
  • TABLE 31 UK COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 58
  • TABLE 32 ITALY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 59
  • TABLE 33 ITALY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 59
  • TABLE 34 ITALY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 59
  • TABLE 35 SPAIN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 60
  • TABLE 36 SPAIN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 60
  • TABLE 37 SPAIN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 60
  • TABLE 38 REST OF EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 61
  • TABLE 39 REST OF EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 61
  • TABLE 40 REST OF EUROPE COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 61
  • TABLE 41 ASIA PACIFIC: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 63
  • TABLE 42 ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 64
  • TABLE 43 ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 64
  • TABLE 44 ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 64
  • TABLE 45 CHINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 65
  • TABLE 46 CHINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 65
  • TABLE 47 CHINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 65
  • TABLE 48 INDIA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 66
  • TABLE 49 INDIA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 66
  • TABLE 50 INDIA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 66
  • TABLE 51 JAPAN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 67
  • TABLE 52 JAPAN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 67
  • TABLE 53 JAPAN COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 67
  • TABLE 54 AUSTRALIA & NEW ZEALAND COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 68
  • TABLE 55 AUSTRALIA & NEW ZEALAND COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 68
  • TABLE 56 AUSTRALIA & NEW ZEALAND COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 68
  • TABLE 57 REST OF ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 69
  • TABLE 58 REST OF ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 69
  • TABLE 59 REST OF ASIA PACIFIC COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 69
  • TABLE 60 SOUTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 71
  • TABLE 61 SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 71
  • TABLE 62 SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 71
  • TABLE 63 SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 72
  • TABLE 64 BRAZIL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 72
  • TABLE 65 BRAZIL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 72
  • TABLE 66 BRAZIL COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 73
  • TABLE 67 ARGENTINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 73
  • TABLE 68 ARGENTINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 73
  • TABLE 69 ARGENTINA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 74
  • TABLE 70 REST OF SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 74
  • TABLE 71 REST OF SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 74
  • TABLE 72 REST OF SOUTH AMERICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 75
  • TABLE 73 MIDDLE EAST & AFRICA: COGNITIVE HEALTH INGREDIENTS MARKET SIZE, BY COUNTRY, 2019-2030 (USD MILLION) 77
  • TABLE 74 MIDDLE EAST & AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 77
  • TABLE 75 MIDDLE EAST & AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 77
  • TABLE 76 MIDDLE EAST & AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 78
  • TABLE 77 GCC COUNTRIES COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 78
  • TABLE 78 GCC COUNTRIES COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 78
  • TABLE 79 GCC COUNTRIES COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 79
  • TABLE 80 TURKEY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 79
  • TABLE 81 TURKEY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 79
  • TABLE 82 TURKEY COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 80
  • TABLE 83 NORTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 80
  • TABLE 84 NORTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 80
  • TABLE 85 NORTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 81
  • TABLE 86 SOUTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2030 (USD MILLION) 81
  • TABLE 87 SOUTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY END-USE, 2019-2030 (USD MILLION) 81
  • TABLE 88 SOUTHERN AFRICA COGNITIVE HEALTH INGREDIENTS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2030 (USD MILLION) 82
  • TABLE 89 MAJOR PLAYERS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • TABLE 90 THE MOST ACTIVE PLAYERS IN THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 84
  • TABLE 91 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL 85
  • TABLE 92 EXPANSION/ACQUISITION/ PARTNERSHIP 85
  • TABLE 93 KEMIN INDUSTRIES, INC.: PRODUCTS OFFERED 86
  • TABLE 94 NEXIRA: PRODUCTS OFFERED 88
  • TABLE 95 NEXIRA: KEY DEVELOPMENTS 88
  • TABLE 96 ARLA FOOD INGREDIENTS GROUP: PRODUCTS OFFERED 91
  • TABLE 97 AUREA BIOLABS: PRODUCTS/SERVICES OFFERED 92
  • TABLE 98 BIORIGINAL FOOD & SCIENCE CORP: PRODUCTS/SERVICES OFFERED 94
  • TABLE 99 BIOTROPICS MALAYSIA BERHAD: PRODUCTS/SERVICES OFFERED 96
  • TABLE 100 NATURAL FACTORS NUTRITIONAL PRODUCTS LTD: PRODUCTS OFFERED 98
  • TABLE 101 NOW FOODS: PRODUCTS/SERVICES OFFERED 100
  • TABLE 102 INTELLIGENT LABS: PRODUCTS OFFERED 102
  • TABLE 103 BASF SE: PRODUCTS OFFERED 105
  • TABLE 104 BASF SE: KEY DEVELOPMENTS 105

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS 15
  • FIGURE 2 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY TYPE 16
  • FIGURE 3 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY END-USE 17
  • FIGURE 4 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 18
  • FIGURE 5 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET ANALYSIS BY REGION 19
  • FIGURE 6 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET: MARKET STRUCTURE 21
  • FIGURE 7 KEY BUYING CRITERIA OF COGNITIVE HEALTH INGREDIENTS 21
  • FIGURE 8 RESEARCH PROCESS OF MRFR 22
  • FIGURE 9 DRO ANALYSIS OF GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 28
  • FIGURE 10 DRIVERS IMPACT ANALYSIS: COGNITIVE HEALTH INGREDIENTS MARKET 30
  • FIGURE 11 RESTRAINTS IMPACT ANALYSIS: COGNITIVE HEALTH INGREDIENTS MARKET 31
  • FIGURE 12 SUPPLY / VALUE CHAIN: GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 35
  • FIGURE 13 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET 36
  • FIGURE 14 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE, 2022 (% SHARE) 38
  • FIGURE 15 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY TYPE, 2019 TO 2030 (USD MILLION) 39
  • FIGURE 16 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE, 2022 (% SHARE) 41
  • FIGURE 17 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY END-USE, 2019 TO 2030 (USD MILLION) 42
  • FIGURE 18 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL, 2022 (% SHARE) 43
  • FIGURE 19 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2030 (USD MILLION) 44
  • FIGURE 20 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION, 2022 TO 2030 (USD MILLION) 45
  • FIGURE 21 GLOBAL COGNITIVE HEALTH INGREDIENTS MARKET, BY REGION, 2022 (% SHARE) 46
  • FIGURE 22 NORTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 48
  • FIGURE 23 EUROPE: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 54
  • FIGURE 24 ASIA PACIFIC: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 63
  • FIGURE 25 SOUTH AMERICA: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 70
  • FIGURE 26 MIDDLE EAST & AFRICA: COGNITIVE HEALTH INGREDIENTS MARKET SHARE, BY COUNTRY, 2022 (% SHARE) 76
  • FIGURE 27 BENCHMARKING OF MAJOR COMPETITORS 83
  • FIGURE 28 KEMIN INDUSTRIES, INC.: SWOT ANALYSIS 87
  • FIGURE 29 NEXIRA: SWOT ANALYSIS 89
  • FIGURE 30 ARLA FOOD INGREDIENTS GROUP: FINANCIAL OVERVIEW SNAPSHOT 90
  • FIGURE 31 ARLA FOOD INGREDIENTS GROUP: SWOT ANALYSIS 91
  • FIGURE 32 AUREA BIOLABS: SWOT ANALYSIS 93
  • FIGURE 33 BIORIGINAL FOOD & SCIENCE CORP: SWOT ANALYSIS 95
  • FIGURE 34 BIOTROPICS MALAYSIA BERHAD: SWOT ANALYSIS 97
  • FIGURE 35 NATURAL FACTORS NUTRITIONAL PRODUCTS LTD: SWOT ANALYSIS 99
  • FIGURE 36 NOW FOODS: SWOT ANALYSIS 101
  • FIGURE 37 INTELLIGENT LABS: SWOT ANALYSIS 103
  • FIGURE 38 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 104
  • FIGURE 39 BASF SE: SWOT ANALYSIS 105